SCHEMBL2180933

SCHEMBL2180933

O=C=Nc1ccccc1Oc1cccc(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 3/20 0.50
SLC6A2 P23975 2/20 0.50
SLC6A3 Q01959 2/20 0.50
LMNA P02545 1/20 0.47
RHEB Q15382 3/20 0.44
HTR1A P08908 1/20 0.44
HTR2A P28223 1/20 0.40
KCNH2 Q12809 1/20 0.40
CYP3A4 P08684 3/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP19A1 P11511 1/20 0.38
PTGS1 P23219 1/20 0.38
PTGS2 P35354 1/20 0.38
EPAS1 Q99814 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7128955 0.89 CYP3A4 (0.46) SLC6A4SLC6A2SLC6A3LMNACYP3A4
SCHEMBL2181422 0.83 HTR2A (0.46) SLC6A4SLC6A2SLC6A3LMNAHTR2A
SCHEMBL673041 0.82 KMT2A (0.44) SLC6A4SLC6A2SLC6A3LMNAHTR1A
SCHEMBL29648775 0.80 CYP3A4 (0.49) LMNARHEBCYP3A4MAPTCYP1A2
SCHEMBL1191181 0.80 CYP1A2 (0.53) LMNACYP3A4MEN1MAPTKMT2A
SCHEMBL160585 0.80 CYP3A4 (0.49) LMNARHEBCYP3A4MAPTCYP1A2
SCHEMBL8485509 0.78 GAA (0.51) SLC6A4LMNACYP3A4MEN1MAPT
SCHEMBL1356140 0.78 CYP3A4 (0.50) CYP3A4ALDH1A1HPGDTDP1
SCHEMBL29369823 0.78 CYP3A4 (0.50) CYP3A4ALDH1A1HPGDTDP1
SCHEMBL1415413 0.76 ALDH1A1 (0.46) SLC6A4SLC6A2SLC6A3LMNAHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748426-B2 Inhibitors of diacylglycerol acyl transferase Piramal Enterprises Limited (IN) 2014-06-10 US disclosed
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Enterprises Limited (IN) 2012-11-15 US disclosed
EP-2519500-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Healthcare Ltd. (IN) 2012-11-07 EP disclosed
WO-2011080718-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE DGAT1, DGAT2, LCAT SLC6A4 1409/4885SLC6A2 694/4885SLC6A3 602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.